1

2
Michael R Myers, Alfred P Spada, Paul E Persons, Martin P Maguire: Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56.sup.lck tyrosine kinases. Aventis Pharmaceuticals Product, Irving Newman, Peter Butch, December 12, 2000: US06159978 (182 worldwide citation)

This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to diso ...


3
Susan C Fazio: Powdered dairy creamer. Peter Butch III, February 8, 1994: US05284674 (19 worldwide citation)

Powdered dairy creamer compositions are disclosed, formed by drying an emulsion containing from about 5% to about 45% by weight of an edible fat component, including one or more edible fats, from about 5% to about 75% by weight of nonfat dry milk solids, from about 0.1% to about 1.0% by weight of a ...


4

5

6
Franco Manfre, Benoit J Vanasse, Richard F Labaudiniere, George C Morton: Functionalized resin for the synthesis of amides and peptides. Aventis Pharmaceuticals Products, Irving Newman, Peter Butch, October 3, 2000: US06127515

This invention is directed to a functionalized amino resin of formula ##STR1## wherein S is a solid support; R is H or alkyl; A is ##STR2## Y is OH or OCOR.sup.1 ; and R.sup.1 is aliphatic or aromatic which is useful for the solid phase synthesis of amides, peptides and hydroxamic acids.